Your browser doesn't support javascript.
loading
Recurrence patterns and impact of brain metastases in synchronous single organ oligometastatic lung cancer following local ablative treatment - A multicenter analysis.
Frost, Nikolaj; Roeper, Julia; Velthaus, Janna-Lisa; Raspe, Matthias; Olive, Elisabeth; Schmittel, Alexander; Schmidt, Bernd; Wasilewski, David; Onken, Julia; Lüders, Heike; Witzenrath, Martin; Senger, Carolin; Böhmer, Dirk; Loges, Sonja; Griesinger, Frank; Modest, Dominik P; Grohé, Christian.
Affiliation
  • Frost N; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Infectious Diseases and Pulmonary Medicine, Berlin, Germany. Electronic address: Nikolaj.frost@charite.de.
  • Roeper J; Department of Internal Medicine-Oncology, Carl v. Ossietzky University of Oldenburg, Pius-Hospital, Oldenburg, Germany; Department of Hematology and Oncology, Pius-Hospital, Oldenburg, Germany; Lung Cancer Network NOWEL Organisation, Pius-Hospital, Oldenburg, Germany.
  • Velthaus JL; Department of Oncology, Hematology and Bone Marrow Transplantation With Section Pneumology, Hubertus Wald University Comprehensive Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Raspe M; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Infectious Diseases and Pulmonary Medicine, Berlin, Germany.
  • Olive E; Klinik für Pneumologie - Evangelische Lungenklinik Berlin Buch, Berlin, Germany.
  • Schmittel A; Onkologie Seestraße, Private Practice for Oncology, Berlin, Germany.
  • Schmidt B; DRK hospital Berlin-Mitte, Department of Pneumonology, Berlin, Germany.
  • Wasilewski D; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Neurosurgery, Berlin, Germany.
  • Onken J; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Neurosurgery, Berlin, Germany; German Cancer Consortium (DKTK), Partner Site Berlin, CCCC (Campus Mitte), Berlin, Germany.
  • Lüders H; Klinik für Pneumologie - Evangelische Lungenklinik Berlin Buch, Berlin, Germany.
  • Witzenrath M; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Infectious Diseases and Pulmonary Medicine, Berlin, Germany; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität B
  • Senger C; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Radiation Oncology, Germany.
  • Böhmer D; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Radiation Oncology, Germany.
  • Loges S; Division of Personalized Medical Oncology (A420), German Cancer Research Center (DKFZ), Heidelberg, Germany, DKFZ-Hector Cancer Institute & Department of Personalized Oncology, University Hospital Mannheim, Medical Faculty Mannheim of the University of Heidelberg, Mannheim, Germany.
  • Griesinger F; Department of Internal Medicine-Oncology, Carl v. Ossietzky University of Oldenburg, Pius-Hospital, Oldenburg, Germany; Department of Hematology and Oncology, Pius-Hospital, Oldenburg, Germany; Lung Cancer Network NOWEL Organisation, Pius-Hospital, Oldenburg, Germany.
  • Modest DP; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Hematology, Oncology and Tumor Immunology, Germany.
  • Grohé C; Klinik für Pneumologie - Evangelische Lungenklinik Berlin Buch, Berlin, Germany.
Lung Cancer ; 170: 165-175, 2022 08.
Article in En | MEDLINE | ID: mdl-35803041
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Brain Neoplasms / Carcinoma, Non-Small-Cell Lung / Lung Neoplasms Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Humans / Middle aged Language: En Journal: Lung Cancer Journal subject: NEOPLASIAS Year: 2022 Document type: Article Country of publication: Irlanda
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Brain Neoplasms / Carcinoma, Non-Small-Cell Lung / Lung Neoplasms Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Humans / Middle aged Language: En Journal: Lung Cancer Journal subject: NEOPLASIAS Year: 2022 Document type: Article Country of publication: Irlanda